Brannelly Paul

Avg. Two Year Performance

< 1% Avg. Purchase Return
0% Compound
23% Avg. Sale Return
11% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return25%21%30%102%< 1%
Purchase Success Rate2 of 22 of 22 of 22 of 21 of 2
Average Sale Return21%< 1%23%35%23%
Sale Success Rate3 of 31 of 31 of 31 of 31 of 3

Collegium Pharmaceutical, Inc

Drugs » Drugs - Generic

Executive Vice President & CFO:

Holdings: 215.43K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Sirtris Pharmaceuticals, Inc.

Drugs » Biotechnology

VP Finance, Treasurer:

Holdings: 31.64K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Karyopharm Therapeutics, Inc.

Drugs » Drug Manufacturers - Major

SVP, FINANCE & ADMIN, TREAS:

Holdings: 66.14K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--